Sakura Kirino
Overview
Explore the profile of Sakura Kirino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogasawara N, Kano Y, Yoneyama Y, Kobayashi S, Watanabe S, Kirino S, et al.
iScience
. 2024 Mar;
27(3):109247.
PMID: 38439969
In normal intestines, a fetal/regenerative/revival cell state can be induced upon inflammation. This plasticity in cell fate is also one of the current topics in human colorectal cancer (CRC). To...
2.
Kirino S, Tamaki N, Kurosaki M, Takahashi Y, Higuchi M, Itakura Y, et al.
Quant Imaging Med Surg
. 2023 Oct;
13(10):6493-6502.
PMID: 37869309
Background: Advanced fibrosis detection in the general population is an unmet need. Additionally, screening method for advanced fibrosis in the general population is not established. Thus, this study aimed to...
3.
Watanabe S, Ogasawara N, Kobayashi S, Kirino S, Inoue M, Hiraguri Y, et al.
J Gastroenterol
. 2023 Feb;
58(4):379-393.
PMID: 36745238
Background: The organoids therapy for ulcerative colitis (UC) is under development. It is important to dissect how the engrafted epithelium can provide benefits for overcoming the vulnerability to inflammation. We...
4.
Keitoku T, Tamaki N, Kurosaki M, Inada K, Kirino S, Uchihara N, et al.
J Viral Hepat
. 2023 Jan;
30(4):297-302.
PMID: 36648382
The number of patients with fatty liver has been increasing worldwide; however, the significance of fatty liver in patients with chronic hepatitis B who are receiving nucleic acid analog (NA)...
5.
Kobayashi S, Ogasawara N, Watanabe S, Yoneyama Y, Kirino S, Hiraguri Y, et al.
Inflamm Regen
. 2022 Nov;
42(1):49.
PMID: 36443773
Background: The emerging concepts of fetal-like reprogramming following tissue injury have been well recognized as an important cue for resolving regenerative mechanisms of intestinal epithelium during inflammation. We previously revealed...
6.
Yamashita K, Kurosaki M, Nakanishi H, Tanaka Y, Ishido S, Inada K, et al.
JGH Open
. 2022 Nov;
6(11):774-781.
PMID: 36406650
Aims: Portopulmonary hypertension (PoPH) is a subtype of pulmonary arterial hypertension related to portal hypertension. The definitive diagnosis of PoPH is made by invasive right heart catheterization. Alternatively, pulmonary arterial...
7.
Kirino S, Tamaki N, Kurosaki M, Kaneko S, Inada K, Tanaka Y, et al.
Hepatol Res
. 2022 Sep;
53(1):35-42.
PMID: 36117296
Aim: Alanine aminotransferase (ALT) is a criterion for the introduction of nucleotide/nucleoside analog (NA), and ALT levels are decreased by NA treatment. However, the association between post-treatment ALT levels and...
8.
Hayakawa Y, Tamaki N, Nakanishi H, Kurosaki M, Tanaka Y, Inada K, et al.
Intern Med
. 2022 Sep;
62(7):973-978.
PMID: 36070941
Objective Rifaximin is used to treat hepatic encephalopathy. However, whether or not rifaximin and lactulose combination therapy can enhance the treatment outcomes and reduce the hospitalization rate of patients with...
9.
Kaneko S, Tsuchiya K, Yasui Y, Tanaka Y, Inada K, Ishido S, et al.
JGH Open
. 2022 May;
6(5):301-308.
PMID: 35601130
Background And Aim: Conversion surgery (CS), which aims to cure after systematic therapy, is only scarcely reported in the field of hepatocellular carcinoma (HCC). However, advancements in systemic therapy for...
10.
Inada K, Tamaki N, Kurosaki M, Kirino S, Yamashita K, Hayakawa Y, et al.
J Gastroenterol Hepatol
. 2022 May;
37(9):1726-1731.
PMID: 35587726
Background And Aim: MEFIB (the combination of magnetic resonance elastography [MRE] ≥ 3.3 kPa and fibrosis-4 (FIB-4) ≥ 1.6) is useful for detecting patients with significant fibrosis (fibrosis stage ≥ ...